Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Ending Market Capitalization in USD by Year
Ending Market Capitalization in USD (USD million, converted from reported USD billion) ($M)
Novartis Ending Market Capitalization in USD: $263,700M in FY2025, up 36.0% from a year earlier.
Latest, FY2025
263,700
Period ended Dec 31, 2025
Change on a year earlier
+36.0%
193,900 in FY2024
History
7 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
“|| Market capitalization (USD billions) 1 | 263.7 | 193.9”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Ending Market Capitalization in USD (USD million, converted from reported USD billion) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 263,700 | +36.0% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 193,900 | -6.0% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2023 | Dec 31, 2023 | 206,300 | – | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 196,100 | -8.5% | Novartis Form 6-K (0001370368-22-000009) ↗ |
| FY2020 | Dec 31, 2020 | 214,300 | -0.2% | Novartis Form 6-K (0001370368-21-000008) ↗ |
| FY2019 | Dec 31, 2019 | 214,800 | +9.0% | Novartis Form 6-K (0001370368-20-000007) ↗ |
| FY2018 | Dec 31, 2018 | 197,000 | – | Novartis Form 6-K (0001370368-19-000006) ↗ |
Cite this data
StockData. (2026). Novartis Ending Market Capitalization in USD ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/share-mcap-usd-b
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.